ATYR Q3 2020 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$148,000-19.6% YoY

Gross Profit

$148,000100.0% margin

Operating Income

-$7M-4400.0% margin

Net Income

-$7M-4458.8% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

-21.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$324,000

Balance Sheet

Total Assets

$42M

Total Liabilities

$10M

Stockholders' Equity

$32M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$148,000	$184,000	-19.6%
Gross Profit	$148,000	$184,000	-19.6%
Operating Income	-$7M	-$5M	-18.4%
Net Income	-$7M	-$6M	-16.9%